We're on a mission to develop a new generation of brain health therapies for the ~1 billion people worldwide suffering from neuropsychiatric and cognitive disorders.
Our novel, rapid-acting drug mechanisms address underlying disease biology by enhancing synaptic function, strengthening neuronal connections, and restoring healthy brain signaling.
Our approach focuses on precision biomarkers and targeted patient populations, and is rooted in learnings from extensive clinical, preclinical, and translational data across thousands of patients with our molecules.
By rethinking what’s possible, we’re creating hope for better mental health treatments and better lives.
To learn more about our clinical-stage, next-generation neuroscience pipeline, please visit our website: https://www.gateneuro.com
Company Details
- Employees
- 2
- Founded
- 2019
- Address
- 1210 Waterway Blvd, Indianapolis,indiana 46202,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- gateneuro.com
- HQ
- Indianapolis, Indiana
Gate Neurosciences Questions
Gate Neurosciences's website is gateneuro.com
Gate Neurosciences's LinkedIn profile is https://www.linkedin.com/company/gate-neurosciences-inc
Gate Neurosciences has
2 employees.
View email and phone details for 2
employees at Gate Neurosciences.
Gate Neurosciences's industry is
Biotechnology Research
Gate Neurosciences's top competitors are
Psilera,
Alto Neuroscience,
Neumora,
Syndeio Biosciences,
Adipo Therapeutics,
Kovina Therapeutics,
Atai Life Sciences,
Beacon Biosignals,
Luson Bioventures,
Monument Biosciences.
Gate Neurosciences's categories are Biotechnology Research
Gate Neurosciences's founding year is 2019
